depression

22nd February 2026 by myeboga

Israeli pharma shakes industry with breakthrough drug

Treatment-resistant depression (TRD) is currently considered one of the most significant challenges in psychiatry: Millions of patients do not respond adequately to existing medications, alongside heavy costs for healthcare systems and ongoing functional loss.

Against this backdrop, the Israeli biopharma company PsyRx is developing an innovative combination drug that seeks to address one of the main failure points of antidepressant treatments – the long time until a significant clinical effect ...

Continue Reading →

Gilgamesh's psychedelic drug demonstrates remarkable efficacy for treating depression

30th May 2025 by Rowan Dunne

Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression

Privately-held Gilgamesh Pharmaceuticals has reported immense success treating depression with its novel psychedelic compound.

On Tuesday, the company dropped data from a Phase 2a study showing that nearly all trial participants suffering from the mental health condition went into remission post-adminstration. Specifically, 70 per cent reported immense alleviation from their major depressive disorder (MDD) within two weeks and 94 per cent went into remission within 30 days.

GM-2505 gets administered via intravenous infusion with ...

Continue Reading →

22nd May 2025 by Rowan Dunne

Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding

Texas is making history by funding a major ibogaine research initiative with an unprecedented sum. As the United States continues to grapple with an increasing rate of mental health conditions, the need for efficacious new treatment modalities is immense.

This is particularly true among the American veterans community. Depression, PTSD, and substance use disorders resulting from those conditions are alarmingly prevalent. So is suicide, unfortunately.

On Thursday, a press release credited to the Texas ...

Continue Reading →

12th December 2020 by myeboga

New Psychedelic Drug Treats Depression Without the Trip, Says Study

Once the psychedelic compound ibogaine was extracted from the African rainforest shrub Tabernanthe iboga, the researchers used a drug-designing …

Source link

Continue Reading →

12th June 2018 by myeboga

Dosed | TRAILER #1 [HD]

Dosed is a feature documentary that has the power to help the 300 million people in the world suffering from illnesses like anxiety and depression, as well as the 1.3 billion people struggling with addictions of all kinds. Please get involved on social media @DoseMovie on instagram, facebook, twitter. Let’s get educated on this important cause and please donate to the film so we can make sure it ...

Continue Reading →